Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
AIFAM Group LLC, founded in 2001, operates from New York and Tokyo, focusing on alternative investments. The firm manages custom portfolios on a discretionary basis for leading Japanese institutions and has overseen over 300 investments and 40 secondary deals. AIFAM also runs the Triple Bridge Acceleration Program (TBAP) in Japan, targeting the medical and life sciences sectors.
AIFAM invests in various stages, including Friends & Family, Angel, and Series A through Series F, primarily in the biotech and healthcare sectors. The firm employs multiple strategies in alternative investments, such as hedge funds, private equity, venture capital, and private credit. Their investment management services leverage extensive networks to identify opportunities.
Email general@aifaminc.com with your pitch deck for consideration.
AIFAM operates the Triple Bridge Acceleration Program (TBAP), which focuses on supporting startups in the medical and life sciences sectors in Japan. Interested founders can apply through the program's official channels.
AIFAM invests across a wide range of stages, from Friends & Family to Series F, allowing them to support companies at various growth phases.
The firm primarily targets investments in the biotech and healthcare sectors, reflecting its expertise and strategic interests.
AIFAM provides investment management services and operates the Triple Bridge Acceleration Program, which supports startups in the medical and life sciences fields in Japan.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.